MACROGENICS INC Contracts & Agreements
86 Contracts & Agreements
- Business Finance (29 contracts)
- Business Operations (10)
- Human Resources (21)
- Intellectual Property (4)
- Real Estate (12)
- Uncategorized (10)
- First Amendment to the Collaboration and License Agreement by and between the Company and Gilead Sciences, Inc., dated (Filed With SEC on May 9, 2024)
- Form of Employee Stock Option Grant Notice and Stock Option Agreement under 2023 Equity Incentive Plan (Filed With SEC on March 7, 2024)
- Form of Employee Restricted Stock Unit Award Grant Notice and Award Agreement under 2023 Equity Incentive Plan (Filed With SEC on March 7, 2024)
- Form of Director Stock Option Grant Notice and Stock Option Agreement under 2023 Equity Incentive Plan (Filed With SEC on March 7, 2024)
- Form of Director Restricted Stock Unit Award Grant Notice and Award Agreement under 2023 Equity Incentive Plan (Filed With SEC on March 7, 2024)
- Amendment No. 2 to the Asset Purchase Agreement by and between the Company and Provention Bio, Inc., dated September 19, 2023 (Filed With SEC on November 6, 2023)
- Purchase and Sale Agreement by and between the Company and DRI Healthcare Acquisitions LP, dated M (Filed With SEC on May 9, 2023)
- Amendment No (Filed With SEC on November 3, 2022)
- Amendment No. 2 to the Global Collaboration and License Agreement by and between the Company and Incyte Corporation, dated April 7, 2022 (Filed With SEC on August 8, 2022)
- Employment Agreement between the Company and Thomas Spitznagel Ph.D (Filed With SEC on May 3, 2022)
- Collaboration and License Agreement by and between the Company and Zai Lab US LLC, dated June 15, 2021 (Filed With SEC on July 29, 2021)
- Stock Purchase Agreement by and between the Company and Zai Lab Limited, dated June 14, 2021 (Filed With SEC on July 29, 2021)
- Employment Agreement between the Company and Stephen Eck, M.D (Filed With SEC on April 29, 2021)
- Amendment No. 1 to Sales Agreement, dated April 29, 2021, between MacroGenics, Inc. and Cowen and Company, LLC (Filed With SEC on April 29, 2021)
- Description of Common Stock (Filed With SEC on February 25, 2021)
- Commercial Supply Agreement by and between (Filed With SEC on February 25, 2021)
- Commercial Supply Agreement by and between Incyte Corporation and the Company, dated (Filed With SEC on February 25, 2021)
- Product Commercialization Agreement by and between the Company and Eversana Life Science Service (Filed With SEC on February 25, 2021)
- Amendment No. 1 to Sales Agreement, dated June 19, 2020, between MacroGenics, Inc. and Cowen and Company, LLC (Filed With SEC on June 19, 2020)
- Amendment No.1 to Employment Agreement between the Company and Scott Koenig, M.D., Ph.D (Filed With SEC on May 5, 2020)
- Description of Common Stock (Filed With SEC on February 25, 2020)
- Third Amendment to the Option for a License Agreement by and between the Company and Les Laboratoires Servier and Institut de Recherches Servier, dated June 6, 2019 (Filed With SEC on July 31, 2019)
- Fourth Amendment to the Option for a License Agreement by and between the Company and Les Laboratoires Servier and Institut de Recherches Servier, dated June 6, 2019 (Filed With SEC on July 31, 2019)
- First Amendment to Option for a License Agreement by and between the Company and Les Laboratoires Servier and Institut de Recherches Servier, dated June 14, 2017 (Filed With SEC on February 26, 2019)
- Second Amendment to Option for a License Agreement by and between the Company and Les Laboratoires Servier and Institut de Recherches Servier, dated March 1, 2018 (Filed With SEC on February 26, 2019)
- Underwriting Agreement, dated February 12, 2019, by and among MacroGenics, Inc. and SVB Leerink LLC and Evercore Group L.L.C., as representatives of the Underwriters (Filed With SEC on February 15, 2019)
- Amendment No, 1 to the Global Collaboration and License Agreement by and between the Company and Incyte Corporation, dated March 15, 2018 (Filed With SEC on May 7, 2018)
- Underwriting Agreement, dated March 27, 2018, by and among MacroGenics, Inc. and Leerink Partners LLC, Deutsche Bank Securities Inc. and Evercore Group L.L.C., as representatives... (Filed With SEC on April 2, 2018)
- MacroGenics,Inc. $75,000,000 Common Stock SALES AGREEMENT (Filed With SEC on May 5, 2017)
- SUBSCRIPTIONAGREEMENT (Filed With SEC on April 27, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 28, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 4, 2016)
- MacroGenics, Inc. 2013 Equity Incentive Plan Restricted Stock Units Grant Notice (Filed With SEC on May 4, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 4, 2016)
- ASSIGNMENT AND ASSUMPTION OF LEASE (9704 Medical Center Drive, Rockville, Maryland) (Filed With SEC on November 4, 2015)
- SECOND AMENDMENT TO LEASE (Filed With SEC on November 4, 2015)
- MACROGENICS, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on July 15, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 6, 2015)
- MacroGenics, Inc. 2013 Equity Incentive Plan Form of Restricted Stock Units Grant Notice (Filed With SEC on May 6, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. INVESTOR AGREEMENT Byand Between JOHNSON &... (Filed With SEC on March 3, 2015)
- MacroGenics, Inc. Second Amendment to Lease Agreement (Filed With SEC on March 3, 2015)
- LEASE (Filed With SEC on March 3, 2015)
- MACROGENICS, INC. LEASE AGREEMENT (Filed With SEC on March 3, 2015)
- MACROGENICS, INC. LEASE AGREEMENT (Filed With SEC on March 3, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT BY AND... (Filed With SEC on March 3, 2015)
- STOCK PURCHASE AGREEMENT By and Between JOHNSON & JOHNSON INNOVATION-JJDC, INC. AND MACROGENICS, INC. Dated as of December 19, 2014 TABLE OF CONTENTS (Filed With SEC on March 3, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AND OPTION AGREEMENT BY AND BETWEEN... (Filed With SEC on August 5, 2014)
- MACROGENICS, INC. (a Delawarecorporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 10, 2014)
- FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT by and among MACROGENICS, INC., THE FOUNDERS, and THE INVESTORS February 3, 2014 TABLE OF CONTENTS (Filed With SEC on February 10, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on January 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. (Filed With SEC on October 4, 2013)
- Confidential Materials omitted and filed separatelywith the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT BY AND BETWEEN MACROGENICS,... (Filed With SEC on October 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. FIRST AMENDMENT (Amendment No. 1) (Filed With SEC on October 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. COLLABORATION AGREEMENT (Filed With SEC on October 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. (Filed With SEC on October 4, 2013)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. OPTION FOR A LICENSE AGREEMENT BY AND BETWEEN... (Filed With SEC on October 4, 2013)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. RESEARCH COLLABORATION AND LICENSE AGREEMENT BY... (Filed With SEC on October 4, 2013)
- MACROGENICS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 1, 2013)
- MACROGENICS, INC. 2013 EQUITY INCENTIVE PLAN (Filed With SEC on October 1, 2013)
- MACROGENICS, INC. 2013 EQUITY INCENTIVE PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on October 1, 2013)
- MACROGENICS, INC. 2013 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on October 1, 2013)
- INDEMNIFICATION AGREEMENT (Filed With SEC on October 1, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 1, 2013)
- MACROGENICS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on October 1, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. Amendment No. 2 toAgreement (Amendment No. 2)... (Filed With SEC on September 20, 2013)
- CONSULTING AGREEMENT (Filed With SEC on September 20, 2013)
- FOURTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT by and among MACROGENICS, INC., THE FOUNDERS, and THEINVESTORS September 19, 2008 TABLE OF CONTENTS (Filed With SEC on September 4, 2013)
- MACROGENICS, INC. 2000 STOCK OPTIONAND INCENTIVE PLAN (Filed With SEC on September 4, 2013)
- MacroGenics, Inc. (Filed With SEC on September 4, 2013)
- 2003 EQUITY INCENTIVE PLAN OF MACROGENICS, INC. TABLE OF CONTENTS (Filed With SEC on September 4, 2013)
- MacroGenics, Inc. (Filed With SEC on September 4, 2013)
- MACROGENICS, INC. LEASE AGREEMENT (Filed With SEC on September 4, 2013)
- Macrogenics, Inc. Amendment to Lease Agreement (Filed With SEC on September 4, 2013)
- LEASE AGREEMENT (Filed With SEC on September 4, 2013)
- MACRO GENICS, INC. Amendment to Lease Agreement (Filed With SEC on September 4, 2013)
- MACRO GENICS, INC. Second Amendment to Lease Agreement (Filed With SEC on September 4, 2013)
- SUBLEASE (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filed separatelywith the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT BY AND BETWEEN MACROGENICS,... (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. COLLABORATION AGREEMENT (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. FIRST AMENDMENT TOCOLLABORATION AGREEMENT (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. AMENDMENT (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. OPTION FOR A LICENSE AGREEMENT BY AND BETWEEN... (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. RESEARCH COLLABORATION AND LICENSE AGREEMENT BY... (Filed With SEC on September 4, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Triple asterisks denote omissions. Amendment No. 1 toAgreement (Amendment No. 1)... (Filed With SEC on September 4, 2013)